Most Popular Stories
- FDA approvals of 2011
- FDA maps out long-awaited rules for the biosimilars business
- Mouse study triggers demands for a possible Alzheimer's treatment
- High price of failure drives drug development costs into the stratosphere
- 13 Big Pharmas to collaborate on $785M fight against neglected diseases
- GSK, Takeda say nay to in-house diagnostics units
Webinars
- Getting the most out of First-in-Human and Early Clinical TrialsIn a follow-up to our webinar last month on first-in-human drug studies, FierceBiotech edi
- Special Studies in Cancer Patients: AME and Cardiac SafetyFierceBiotech Editor John Carroll will moderate an expert panel discussion exploring how c
- Webinar: Next Gen Sequencing from FFPE SamplesNext generation sequencing (NGS) technologies hold enormous promise to advance personalize
- Prepare Your Compliance Systems and Processes for the Physician Payments Sunshine ActBeginning in 2012, pharmaceutical, biotechnology and medical device companies will be requ
Featured Jobs
-
Docket Clerk Job
Celgene Corporation - Summit, NJ, US -
Program Lead - Scientific Information Architecture & Search
Merck - Kenilworth, NJ -
Sr. Director, Alliance Management Job
Celgene Corporation - Summit, NJ, US -
Benefits Specialist Job
Celgene Corporation - Summit, NJ, US -
Associate Manager, Global Supply Chain Planning (1 of 3) Job
Celgene Corporation - Basking Ridge, NJ, US
Popular Topics
Events
- DCAT Week 2012
Mar 12-15 — New York City - DCAT Week '12 Biologics Forum & Networking Reception
Mar 14 — New York City - Connect, Collaborate, & Innovate: MassBio Annual Meeting
March 26-27 — Cambridge, MA - Pharmaceutical Strategic Outlook
April 11-13, 2012 — Grand Hyatt, New York
Eli Lilly President Deidre Connelly
Tools


SHARE
WITH: